Jci_page_head_homepage_01 Jci_page_head_homepage_02
This page
  • Citations to this article
David A. Hafler
Published in Volume 104, Issue 5
J Clin Invest. 1999; 104(5):527 doi:10.1172/JCI8193
Full text | PDF
Citation information
  • Citation in:
  • Citations:
  • 2010
  • 1
  • 2007
  • 2
  • 2006
  • 2
  • 2005
  • 3
  • 2004
  • 1
  • 2002
  • 4
  • 2001
  • 1
  • 2000
  • 2
  • Total
  • 8
 
Title and authors Publication Year .
99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence
A. Ascherio, K. L. Munger
Clin Exp Immunol 2010 .
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio, Kassandra L. Munger
Annuals of Neurology 2007 .
New Therapeutic Approaches for Multiple Sclerosis
Philip L. De Jager, David A. Hafler
Annu Rev Med 2007 .
Inflammation in white matter: Clinical and pathophysiological aspects
David Pleasure, Athena Soulika, Sunit K. Singh, Vittorio Gallo, Peter Bannerman
Ment Retard Dev Disabil Res Rev 2006 .
Contribution of peptides to multiple sclerosis research
Maria Claudia Alcaro, Anna Maria Papini
Biopolymers 2006 .
Role of Magnetic Resonance Imaging and Immunotherapy in Treating Multiple Sclerosis*
Jingwu Zhang, George Hutton
Annu Rev Med 2005 .
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses
Tove Christensen
Rev Med Virol 2005 .
Multiple sclerosis
David A. Hafler, Jacqueline M. Slavik, David E. Anderson, Kevin C. O'Connor, Philip De Jager, Clare Baecher-Allan
Immunol Rev 2005 .
Multiple sclerosis
David A. Hafler
J Clinic Invest 2004 .
T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis
Jingwu Zhang
Expert Rev Vaccine 2002 .
Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients
Cecilia Rajda, Krisztina Bencsik, László Vécsei L, Jonas Bergquist
J Neuroimmunol 2002 .
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?
Richard K. Burt, Shimon Slavin, William H. Burns, Alberto M. Marmont
Int J Hematol 2002 .
A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis
Jingwu Zhang, George Hutton, Ying Zang
CLIN THER 2002 .

Canan Yucesan, Subramaniam Sriram
Curr Opin Neurol 2001 .
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
Petra W. Duda, Mascha C. Schmied, Sandra L. Cook, Jeffrey I. Krieger, David A. Hafler
J Clinic Invest 2000 .

Cristen Willer, G. Ebers
Curr Opin Neurol 2000 .